Skip to main content

Table 1 Clinical characteristics and surgical outcomes

From: Improvement in early urinary continence recovery after robotic-assisted radical prostatectomy based on postoperative pelvic anatomic features: a retrospective review

  Patients who underwent postoperative prostate MRI (n = 73) Patients in the whole series (n = 301)
Age (years; mean ± SD; range) 67.9 ± 5.4 (53–76) 68.7 ± 4.7 (53–76)
BMI (kg/m2; mean ± SD; range) 24.1 ± 2.8 (18.9–30.7) 23.9 ± 2.8 (16.8–33.4)
Preoperative PSA level (ng/mL; mean ± SD; range) 9.9 ± 6.9 (4.0–43.4) 9.5 ± 6.6 (4.0–57.1)
Clinical T stage (n, %)
 cT1 23 (30.3)   148 (49.2)  
 pT2 49 (67.1)   136 (45.2)  
 pT3 1 (1.4)   17 (5.6)  
Biopsy Gleason’s score (n, %)
6 25 (34.2)   94 (31.2)  
 = 7 30 (41.1)   137 (45.5)  
8 18 (24.7)   70 (23.3)  
Operative time (min; mean ± SD; range) 182.3 ± 48.8 (108–307) 187.3 ± 44.4 (103–313)
Console time (min; mean ± SD; range) 141.0 ± 41.7 (76–250) 145.6 ± 41.3 (74–289)
Estimated blood loss (mL; mean ± SD; range) 98.1 ± 76.6 (2–380) 93.3 ± 99.4 (1–650)
Prostate volume (mL; mean ± SD; range) 50.2 ± 24.2 (10–175) 44.1 ± 18.9 (10–175)
Pathological T stage (n, %)
 pT2 57 (78.1)   226 (75.1)  
 pT3 16 (21.9)   75 (24.9)  
Positive surgical margins (n, %)
 All stages 11 (15.1)   62 (20.1)  
 pT2 7 (12.3)   29 (12.8)  
 pT3 4 (25.0)   33 (44.0)  
Catheter removal period (days; mean ± SD; range) 7.2 ± 0.8 (6–13) 7.5 ± 3 (4–45)
Postoperative hospital stay (days; mean ± SD; range) 10.7 ± 2.2 (8–20) 10.9 ± 4.9 (7–49)
% continence (%)
 ≤ 1 month 27.4   31.7  
 ≤ 3 months 53.4   51.2  
 ≤ 6 months 68.5   70.3  
 ≤ 12 months 84.9   78.8  
  1. Abbreviations: BMI Body mass index, PSA Prostate-specific antigen, SD Standard deviation